The ambr250 unit is a fully automated disposable 100-250 ml bioreactor for R&D that has been developed by TAP Biosystems, now part of Sartorius-Stedim, widely used for scale down and scale up modelling studies. Recently, mesenchymal stem cells (MSCs) have become strong candidates for cell-based therapies based on in vitro growth on microcarriers in stirred bioreactors. However, to fully realize the MSCs potential, a number of key processing issues need to be addressed because of the huge number of cells that are required. Thus, the fluid dynamics characteristics of the stirred ambr250 bioreactor must be sufficiently well understood to enable scale-up to larger bioreactors to be efficiently accomplished particularly because of the special is...
Improvements to process development technology will have a significant impact in reducing the overal...
The impact of agitation rate and sparged aeration on BM-hMSC expansion in conventional stirred tank ...
Industry trends in regenerative medicine show an increased need for scalable and closed manufacturin...
Renewed interest in microcarrier-based processes for the large-scale culture of adherent cells for v...
Interest for microcarrier-based processes for the large-scale culture of adherent cells has recently...
The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a la...
There is a growing necessity for cell cultivation using bioreactors to translate laboratory based cu...
Hydrodynamic variables in bioreactors such as velocity, shear rate, and energy dissipation rate have...
Computational Fluid Dynamics (CFD) is an established method in fluid mechanics that allows fluidic p...
The expansion of hMSC adhered on microcarriers is a proven technology to allow the production of qua...
The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a la...
The use of computational fluid dynamics (CFD) techniques can be used to develop and/or optimize a sc...
Embryonic stem cells have a large potential to help patients with commonly known diseases such as Pa...
Improvements to process development technology will have a significant impact in reducing the overal...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
Improvements to process development technology will have a significant impact in reducing the overal...
The impact of agitation rate and sparged aeration on BM-hMSC expansion in conventional stirred tank ...
Industry trends in regenerative medicine show an increased need for scalable and closed manufacturin...
Renewed interest in microcarrier-based processes for the large-scale culture of adherent cells for v...
Interest for microcarrier-based processes for the large-scale culture of adherent cells has recently...
The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a la...
There is a growing necessity for cell cultivation using bioreactors to translate laboratory based cu...
Hydrodynamic variables in bioreactors such as velocity, shear rate, and energy dissipation rate have...
Computational Fluid Dynamics (CFD) is an established method in fluid mechanics that allows fluidic p...
The expansion of hMSC adhered on microcarriers is a proven technology to allow the production of qua...
The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a la...
The use of computational fluid dynamics (CFD) techniques can be used to develop and/or optimize a sc...
Embryonic stem cells have a large potential to help patients with commonly known diseases such as Pa...
Improvements to process development technology will have a significant impact in reducing the overal...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
Improvements to process development technology will have a significant impact in reducing the overal...
The impact of agitation rate and sparged aeration on BM-hMSC expansion in conventional stirred tank ...
Industry trends in regenerative medicine show an increased need for scalable and closed manufacturin...